Skip to main content

Combined Chemo-Radiotherapy with Carboplatin, 5-Fluorouracil and Folinic Acid for Cancer of the Urinary Bladder: Acute and Late Side Effects

  • Conference paper
Acute and Long-Term Side-Effects of Radiotherapy

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 130))

  • 135 Accesses

Abstract

Conventional treatment of advanced bladder carcinoma included surgery, or preoperative irradiation combined with surgery. Results of cystectomy alone and irradiation/surgery for T3 tumors achieved 5-year survival rates up to 40% (Jacobi et al. 1983) and 40%–50% (van der Werf-Messing 1983). 5-Fluorouracil (5-FU), mitomycin C and cisplatin were shown to be useful as radiosensitizers in invasive bladder carcinoma. Rotman et al. (1987) and Russel et al. (1988) demonstrated an advantage for 5-year disease-free survival using irradiation and chemotherapy with 5-FU and mitomycin C. Sauer et al. (1988) and Shipley et al. (1984, 1985) reported similarly complete response rates with cisplatin and irradiation. However, cisplatin is a potentially more toxic drug, especially as regards its neurotoxicity and nephrotoxicity (Lelieveld et al. 1984).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Arbuck SG (1989) Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer [Suppl] 63: 1036–1044

    CAS  Google Scholar 

  • Jacobi GH, Klippel KH, Hohenfellner R (1983) Fifteen years’ experience with radical cystectomy without preoperative radiotherapy or radiotherapy for bladder cancer. Aktuel Urol 14: 63–70

    Article  Google Scholar 

  • Jakse G, Rauschmeier H, Fritsch E, Frommhold H, Marberger H (1986) Die integrierte Radiotherapie des lokal fortgeschrittenen Harnblasenkarzinoms. Actuel Urol 17: 68–73

    Article  Google Scholar 

  • Lelieveld P, Vijgh WJF, Vildhuizen RW, van Velzen D, Putten LM, Atassi G, Danguy A (1984) Preclinical studies on toxicity, antitumor activity and pharmacokinetics of cis-platin and three recently developed derivates. Eur J Cancer Clin Oncol 20: 1087–1104

    Article  PubMed  CAS  Google Scholar 

  • Marks BL, Kaufman SD, Prout G, Heney NM, Griffin PP, Shipley WU (1988) Invasive bladder carcinoma: preliminary report of selective bladder conservation by transurethral surgery, upfront MCV chemotherapy and pelvic irradiation plus cisplatin. Int J Radiat Oncol Biol Phys 15: 877–883

    Article  PubMed  CAS  Google Scholar 

  • Rotman M, Macchia R, Silverstein M, Aziz H, Choi K, Rosenthal J, Braverman A, Laungani GB (1987) Treatment of advanced bladder carcinoma with irradiation and concomitant 5-fluorouracil infusion. Cancer 59: 710–714

    Article  PubMed  CAS  Google Scholar 

  • Russel KJ, Boileau MA, Ireton R (1988) Transitional cell carcinoma of the urinary bladder: histologic clearance with combined 5-FU chemotherapy and radiation therapy: preliminary results of a bladder-preservation study. Radiology 167: 845–850

    Google Scholar 

  • Sauer R, Schrott KM, Dunst J, Thiel HJ, Hermanek P, Bornhof C (1988) Preliminary results of treatment of invasive bladder carcinoma with radiotherapy and cisplatin. Int J Radiat Oncol Biol Phys 15: 871–875

    Article  PubMed  CAS  Google Scholar 

  • Schwachöfer JHM, Crooijmans RP, Hoogenhout J, Kal HB, Theeuwes AGM (1991) Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. Int J Radiat Oncol Biol Phys 20: 1235–1241

    Article  PubMed  Google Scholar 

  • Shipley W, Einstein AB, Soloway MS, Wajsman Z, Prout GR and the National Bladder Collaborative Group A (1984) Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response. J Urol 132: 899–903

    PubMed  CAS  Google Scholar 

  • Shipley W, Rose MA, Perrone TL, Mannix CM, Henry NM, Prout GR (1985) Full dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol 134: 679–683

    PubMed  CAS  Google Scholar 

  • Van der Werf-Messing B (1983) Carcinoma of the bladder treated by preoperative irradiation followed by cystectomy. Cancer 32: 1084–1088

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Wiegel, T., Lorenzen, J., Brockmann, WP., Lopez, B., Schwarz, R., Hübener, KH. (1993). Combined Chemo-Radiotherapy with Carboplatin, 5-Fluorouracil and Folinic Acid for Cancer of the Urinary Bladder: Acute and Late Side Effects. In: Hinkelbein, W., Bruggmoser, G., Frommhold, H., Wannenmacher, M. (eds) Acute and Long-Term Side-Effects of Radiotherapy. Recent Results in Cancer Research, vol 130. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84892-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84892-6_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-84894-0

  • Online ISBN: 978-3-642-84892-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics